|
1
|
Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan
Y, Huang L, Wu ZX, Zhang JY and Ding X: Cholesterol promotes
EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1
signaling-mediated ERRα re-expression. Mol Cancer. 21:772022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng C, Wang S, Dong J, Zhang S, Yu D and
Wang Z: Effects of targeted lung cancer drugs on cardiomyocytes
studied by atomic force microscopy. Anal Methods. 15:4077–4084.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mok TS, Wu YL, Ahn MJ, Garassino MC, Kim
HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, et
al: Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung
cancer. N Engl J Med. 376:629–640. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thein KZ, Swarup S, Ball S, Quirch M,
Vorakunthada Y, Htwe KK, D'Cunha N, Hardwicke F, Awasthi S and
Tijani L: 1388P Incidence of cardiac toxicities in patients with
advanced non-small cell lung cancer treated with osimertinib: A
combined analysis of two phase III randomized controlled trials.
Ann Oncol. 29:viii5002018. View Article : Google Scholar
|
|
5
|
Soria JC, Ohe Y, Vansteenkiste J,
Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura
F, Nogami N, Kurata T, et al: Osimertinib in untreated EGFR-mutated
advanced non-small-cell lung cancer. N Engl J Med. 378:113–125.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang M, Chen X, Yu F, Zhang L, Zhang Y and
Chang W: The targeting of noncoding RNAs by quercetin in cancer
prevention and therapy. Oxid Med Cell Longev.
2022:43306812022.PubMed/NCBI
|
|
7
|
Güran M, Şanlıtürk G, Kerküklü NR,
Altundağ EM and Süha Yalçın A: Combined effects of quercetin and
curcumin on anti-inflammatory and antimicrobial parameters in
vitro. Eur J Pharmacol. 859:1724862019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ersoz M, Erdemir A, Derman S, Arasoglu T
and Mansuroglu B: Quercetin-loaded nanoparticles enhance
cytotoxicity and antioxidant activity on C6 glioma cells. Pharm Dev
Technol. 25:757–766. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sul OJ and Ra SW: Quercetin Prevents
LPS-induced oxidative stress and inflammation by modulating
NOX2/ROS/NF-kB in lung epithelial cells. Molecules. 26:69492021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lan CY, Chen SY, Kuo CW, Lu CC and Yen GC:
Quercetin facilitates cell death and chemosensitivity through
RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells. J Food
Drug Anal. 27:887–896. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hasan AAS, Kalinina EV, Tatarskiy VV,
Volodina YL, Petrova АS, Novichkova MD, Zhdanov DD and Shtil AA:
Suppression of the antioxidant system and PI3K/Akt/mTOR signaling
pathway in cisplatin-resistant cancer cells by quercetin. Bull Exp
Biol Med. 173:760–764. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Zhou N, Wang J, Liu Z, Wang X, Zhang
Q, Liu Q, Gao L and Wang R: Quercetin suppresses breast cancer stem
cells (CD44(+)/CD24(−)) by inhibiting the PI3K/Akt/mTOR-signaling
pathway. Life Sci. 196:56–62. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Y, Suo W, Zhang X, Lv J, Liu Z and
Liu R: Roles and mechanisms of quercetin on cardiac arrhythmia: A
review. Biomed Pharmacother. 153:1134472022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Tan A, An X, Xia Y and Xie Y:
Quercetin dihydrate inhibition of cardiac fibrosis induced by
angiotensin II in vivo and in vitro. Biomed Pharmacother.
127:1102052020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang KY, Wang TH, Chen CC, Leu YL, Li HJ,
Jhong CL and Chen CY: Growth suppression in lung cancer cells
harboring EGFR-C797S mutation by quercetin. Biomolecules.
11:12712021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The cancer cell line encyclopedia enables
predictive modelling of anticancer drug sensitivity. Nature.
483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heliste J, Jokilammi A, Vaparanta K,
Paatero I and Elenius K: Combined genetic and chemical screens
indicate protective potential for EGFR inhibition to cardiomyocytes
under hypoxia. Sci Rep. 11:166612021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sunasee R, Araoye E, Pyram D, Hemraz UD,
Boluk Y and Ckless K: Cellulose nanocrystal cationic derivative
induces NLRP3 inflammasome-dependent IL-1β secretion associated
with mitochondrial ROS production. Biochem Biophys Rep. 4:1–9.
2015.PubMed/NCBI
|
|
20
|
Greenhalgh J, Boland A, Bates V, Vecchio
F, Dundar Y, Chaplin M and Green JA: First-line treatment of
advanced epidermal growth factor receptor (EGFR) mutation positive
non-squamous non-small cell lung cancer. Cochrane Database Syst
Rev. 3:CD0103832021.PubMed/NCBI
|
|
21
|
Hou X, Li M, Wu G, Feng W, Su J, Jiang H,
Jiang G, Chen J, Zhang B, You Z, et al: Gefitinib plus chemotherapy
vs gefitinib alone in untreated EGFR-mutant non-small cell lung
cancer in patients with brain metastases: The GAP BRAIN open-label,
randomized, multicenter, phase 3 study. JAMA Netw Open.
6:e22550502023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wilkaniec A, Cieślik M, Murawska E, Babiec
L, Gąssowska-Dobrowolska M, Pałasz E, Jęśko H and Adamczyk A: P2X7
receptor is involved in mitochondrial dysfunction induced by
extracellular alpha synuclein in neuroblastoma SH-SY5Y cells. Int J
Mol Sci. 21:39592020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong Y, Zhou X, Li Q, Chen J, Wei Y, Long
C, Shen L, Zheng X, Li D, Wang X, et al: X-box binding protein 1
caused an imbalance in pyroptosis and mitophagy in immature rats
with di-(2-ethylhexyl) phthalate-induced testis toxicity. Genes
Dis. 11:935–951. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Imberechts D, Kinnart I, Wauters F,
Terbeek J, Manders L, Wierda K, Eggermont K, Madeiro RF, Sue C,
Verfaillie C and Vandenberghe W: DJ-1 is an essential downstream
mediator in PINK1/parkin-dependent mitophagy. Brain. 145:4368–4384.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu M, Hang H, Huang M, Li J, Xu D, Jiao J,
Wang F, Wu H, Sun X, Gu J, et al: DJ-1 deficiency in hepatocytes
improves liver ischemia-reperfusion injury by enhancing mitophagy.
Cell Mol Gastroenterol Hepatol. 12:567–584. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu G, Xie J, Kong W, Xie J, Li Y, Du L,
Zheng Q, Sun L, Guan M, Li H, et al: Phase separation of
disease-associated SHP2 mutants underlies MAPK hyperactivation.
Cell. 183:490–502.e18. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Chen H, Xie X, Yang B, Wang X, Zhang
J, Qiao T, Guan J, Qiu Y, Huang YX, et al: PINK1-mediated mitophagy
promotes oxidative phosphorylation and redox homeostasis to induce
drug-tolerant persister cancer cells. Cancer Res. 83:398–413. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Ho PW, Leung CT, Pang SY, Chang
EES, Choi ZY, Kung MH, Ramsden DB and Ho SL: Aberrant mitochondrial
morphology and function associated with impaired mitophagy and
DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian
LRRK2R1441G mice. Autophagy. 17:3196–3220. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo T, Jia X, Feng WD, Wang JY, Xie F,
Kong LD, Wang XJ, Lian R, Liu X, Chu YJ, et al: Bergapten inhibits
NLRP3 inflammasome activation and pyroptosis via promoting
mitophagy. Acta Pharmacol Sin. 44:1867–1878. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Z, Wang M, Wang X, Bu Q, Wang Q, Su W,
Li L, Zhou H and Lu L: XBP1 deficiency promotes hepatocyte
pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING
signaling in macrophages during acute liver injury. Redox Biol.
52:1023052022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Di Petrillo A, Orrù G, Fais A and Fantini
MC: Quercetin and its derivates as antiviral potentials: A
comprehensive review. Phytother Res. 36:266–278. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reyes-Farias M and Carrasco-Pozo C: The
anti-cancer effect of quercetin: Molecular implications in cancer
metabolism. Int J Mol Sci. 20:31772019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang B, Zhang W, Zhou X, Liu M, Hou X,
Cheng Z and Chen D: Development of dual-targeted nano-dandelion
based on an oligomeric hyaluronic acid polymer targeting
tumor-associated macrophages for combination therapy of non-small
cell lung cancer. Drug Deliv. 26:1265–1279. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang SM, Deng XT, Zhou J, Li QP, Ge XX and
Miao L: Pharmacological basis and new insights of quercetin action
in respect to its anti-cancer effects. Biomed Pharmacother.
121:1096042020. View Article : Google Scholar : PubMed/NCBI
|
